Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of ciclopirox olamine cream versus hydrocortisone cream versus emollient cream for mild to moderate atopic eczema
2005-002471-32Phase 2
- Sponsor
- Stiefel Laboratories
- Start
- Jul 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of ciclopirox, Alkindi Sprinkle and E45 Cream in atopic dermatitis (AD) (3 arms), sponsored by Stiefel Laboratories. Primary endpoint: Reduction in eczema signs by SASSAD.
02
Drugs
ciclopiroxAlkindi SprinkleE45 Cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2005-002471-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002471-32.